Science and Engineering Ethics

, 9:319

Parallel path: Poliovirus research in the vaccine era

Article
  • 43 Downloads

Abstract

One goal of the scientific research enterprise is to improve the lives of individuals and the overall health of societies. This goal is achieved through a combination of factors, including the composition of research portfolios. In turn, this composition is determined by a variety of scientific and societal needs. The recent history of polio research highlights the complex relations between research policy, scientific progress and societal benefits. Here, we briefly review the circumstances leading to the possibility of eradication of poliovirus, evaluate the research environment that emerged following the introduction of a vaccine, and compare and contrast the current research framework with that for other infectious diseases. From this analysis, policy lessons with general applicability to scientific research are identified.

Keywords

scientific responsibility societal outcomes research policy 

References

  1. 1.
    Smith, J.S. (1990) Patenting the Sun: Polio and the Salk Vaccine, Anchor Books (Doubleday, New York).Google Scholar
  2. 2.
    Centers for Disease Control and Prevention. (2001) Epidemiology and Prevention of Vaccine-Preventable Diseases 6th Edition, Centers for Disease Control and Prevention (Department of Health and Human Services, United States). Also available at http://www.cdc.gov/nip/publications/pink/polio.pdf (accessed 10 January 2002).Google Scholar
  3. 3.
    March of Dimes. (2001) After Effects of Polio Can Harm Survivors 40 Years Later, http://www.modimes.org/About2/PressReleases/2001/PolioCanHarm.htm (accessed 10 January 2002).Google Scholar
  4. 4.
    World Health Organization, global Programme for Vaccines and Immunization. (1998) Report of the Technical Review Group Meeting, Geneva, Switzerland.Google Scholar
  5. 5.
    Seavey, N.G., Smith, J.S. and Wagner, P. (1998) A Paralyzing Fear, TV Books, Inc. (New York).Google Scholar
  6. 6.
    Blume, S. and Geesink, I. (2000) A Brief History of Polio Vaccines, Science 288: 1593–1594.CrossRefGoogle Scholar
  7. 7.
    Sutter, R.W., Cochi, S.I. and Melnick, J.L. (1999) Live attenuated Polio Vaccines. In: Plotkin, S.A. and Orenstein, W.A., eds. Vaccines 3rd Edition, W.B. Saunders Company, Philadelphia (Pennsylvania).Google Scholar
  8. 8.
    Dowdle, W.R., Cochi, S.L., Oberste, S. and Sutter, R. (2001) Preventing Polio from Becoming a Reemerging Disease, Emerging Infectious Diseases 7 (Supplement): 549–550.CrossRefGoogle Scholar
  9. 9.
    Dove, A.W. and Racaniello, V.R. (1997) The Polio Eradication Effort: Should Vaccine Eradication be Next? Science 277: 779–780.CrossRefGoogle Scholar
  10. 10.
    Gladwell, M. (2001) Annals of Public Health: The Mosquito Killer, The New Yorker, 2 July.Google Scholar
  11. 11.
    Centers for Disease Control and Prevention (1997) Paralytic Poliomyelitis—United States, 1980–1994, Morbidity and Mortality Weekly Report 46: 79–83.Google Scholar
  12. 12.
    World Health Assembly of the World Health Organization. (1988) Resolution WHA41.28, Geneva, Switzerland.Google Scholar
  13. 13.
    World Health Organization. (2000) On Track for a World Certified Polio-Free in 2005, But Intensified Efforts Needed, Press Release WHO/33.Google Scholar
  14. 14.
    Centers for Disease Control and Prevention. (1999) Recommendations of the Advisory Committee on Immunization Practices: Revised Recommendations for Routine Poliomyelitis Vaccination, Morbidity and Mortality Weekly Report 48: 590.Google Scholar
  15. 15.
    Lee, J.W. (1995) Ending Polio—Now or Never? In UNICEF, The Progress of Nations: Action on Polio, http://www.unicef.org/pon95/heal0002.html.Google Scholar
  16. 16.
    World Health Organization. National Immunization Days: Calendar, http://www.polioeradication.org/nidcalendar.htm (accessed 10 January 2002).Google Scholar
  17. 17.
    World Health Organization. (1997) Global Polio Eradication Campaign: WHO and UNICEF To Broker “Days of Tranquility” in Afghanistan, Press release WHO/9. Available at http://www.who.int/archives/inf-pr-1997/en/pr97-09.html (accessed 10 January 2002).Google Scholar
  18. 18.
    World Health Organization (2002) Polio Case Count, http://www.who.int/vaccines/casecount/case_count.cfm (accessed 10 January 2002).Google Scholar
  19. 19.
    National Science Foundation (2000) Twelve Pioneering Researchers Will Receive the 1999 National Medal of Science, http://www.nsf.gov/od/lpa/news/press/00/pr0003.htm (accessed 20 June 2003).Google Scholar
  20. 20.
    Crotty, S. (2001) Ahead of the Curve: David Baltimore’s Life in Science, University of California Press, Berkeley.Google Scholar
  21. 21.
    National Institutes of Health Computer Retrieval of Information on Scientific Projects, http://crisp.cit.nih.gov/ (accessed 20 June 2003).Google Scholar
  22. 22.
    National Institutes of Health, Office of Intramural Research Grants http://grants.nih.gov/grants/oer.htm (accessed 10 January 2002).Google Scholar
  23. 23.
    National Institutes of Health. (2001) Activity Codes, Organization Codes, and Definitions Used in Extramural Programs, User Support Branch, Division of Extramural Information Systems, Office of Extramural Research. Also available at http://grants.nih.gov/grants/funding/ac.pdfGoogle Scholar
  24. 24.
    National Academy of Public Administration. (2001) A Study of the National Science Foundation’s Criteria for Project Selection, Washington. Also available at http://www.napawash.org/napa/nsfreport.pdf (accessed 10 January 2002).Google Scholar
  25. 25.
    Chen, R.T. and Hibbs, B. (1998) Vaccine Safety: Current and Future Challenges, Pediatric Annals 27: 445–455.Google Scholar
  26. 26.
    National Academy of Sciences. (1996) Colloquium: Genetic Engineering of Viruses and Viral Vectors.Google Scholar
  27. 27.
    Stokes, D.E. (1997). Pasteur’s Quadrant: Basic Science and Technological Innovation, Brookings Institution Press, Washington, District of Columbia.Google Scholar
  28. 28.
    Bush, V. (1945) Science, The Endless Frontier: A Report to the President by Vannevar Bush, Director of the Office of Scientific Research and Development, United States Government Printing Office, Washington (District of Columbia). Also available at http://www1.umn.edu/scitech/VBush1945.html (accessed 10 January 2002).Google Scholar
  29. 29.
    Office of the Director, National Institutes of Health. (Undated) Setting Research Priorities at the National Institutes of Health, Section II, “How Science Works.” Available at http://www.nih.gov/news/ResPriority/priority.htm (accessed 10 January 2002).Google Scholar
  30. 30.
    Kolata, G. (2001) On Research Frontier, Basic Questions, The New York Times (5 June). Health Section Front. Also available at http://www.nytimes.com/2001/06/05/health/05FRON.html (accessed 10 January 2002).Google Scholar
  31. 31.
    Epstein, S. (1996) Impure Science: AIDS, Activism, and the Politics of Knowledge, University of California Press.Google Scholar
  32. 32.
    Gonsalves, Gregg (2000) NIH-Funded AIDS Vaccine Research: A Critical Review, http://www.aidsinfonyc.org/tag/science/vaccines.html.Google Scholar
  33. 33.
    Kuhn, T.S. (1970) The Structure of Scientific Revolutions, The University of Chicago Press, Illinois.Google Scholar
  34. 34.
    National Research Council (1998) Assessing the Value of Research in the Chemical Sciences, National Academy Press, Washington.Google Scholar
  35. 35.
    Kitcher, P. (1995) The Advancement of Science: Science without Legend, Objectivity Without Illusions, Oxford University Press, Oxford.Google Scholar
  36. 36.
    Merton, R.K. (1973) The Sociology of Science: Theoretical and Empirical Investigations, University of Chicago Press, Illinois.Google Scholar
  37. 37.
    Fauci, A.S. (1998) Global Health: The United States Response to Infectious Diseases, Testimony before the U.S. Senate Labor and Human Resources Subcommittee on Public Health and Safety. Available at http://www.niaid.nih.gov/director/congress/1998/0303/posters/poster8.htm (accessed 10 January 2002).Google Scholar
  38. 38.
    World Health Organization. (2000) Onchocerciasis (River Blindness), Fact Sheet Number 95. Available at http://www.who.int/inf-fs/en/fact095.html (accessed 10 January 2002).Google Scholar
  39. 39.
    World Health Organization (1996) Schistosomiasis, Fact Sheet Number 115. Available at http://www.who.int/inf-fs/en/fact115.html (accessed 10 January 2002).Google Scholar
  40. 40.
    World Health Organization. (1998) Dracunculiasis Eradication, Fact Sheet Number 98. Available at http://www.who.int/inf-fs/en/fact098.html (accessed 10 January 2002).Google Scholar
  41. 41.
    Colley, D.G., LoVerde, P.T. and Savioli, L. (2001) Medical Helminthology in the 21st Century, Science 293: 1437–1438.CrossRefGoogle Scholar
  42. 42.
    Garfinkel, M.S. (2000) Biomedical Gerrymandering, Recent Science Newsletter 2: 4–7.Google Scholar

Copyright information

© Opragen Publications 2003

Authors and Affiliations

  1. 1.Center for Science, Policy, & OutcomesWashington, D.C.
  2. 2.The Center for the Advancement of GenomicsRockvilleUSA

Personalised recommendations